- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Teva Launches Social Media Campaign on Optimal Inhaler Use
Teva Pharmaceuticals Europe announced the launch of its Get It Right disease awareness campaign. The campaign focuses on increasing awareness and dialogue on the correct usage of asthma inhalers. It aims to challenge the public’s and physician’s min-set in managing asthma by calling attention to poor inhaler techniques while using social media and creating other media content and resources to educate people for World Asthma Day on May 2.
Using social media, the initiative is to spread the message by using hashtags #Getitright and #worldasthmaday. Additionally, a livestream broadcast will be provided to healthcare professionals on June 6, entitled Breathing New Life Into Inhalation Technology – Inside Out, An Exploration of Inhalers. The webinar will be chaired by Prof. Dr. J. Christian Virchow, Head of Department of Pneumology, University of Rostock, Germany will speak to the do’s and don’ts of inhaler techniques and how to help those affected by asthma. To register for the broadcast visit http://letstalkrespiratory.eu/inhalationtechnology
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
